Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the population requiring more healthcare and support. The company is proactively meeting the unique needs of this rapidly aging group by providing healthcare services that are culturally sensitive and honor the diverse traditions and […]

Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries, recently released financial results for the three months ended December 31, 2023 (“Q2 2024”). The company recorded a 512% jump in its year-to-date (“YTD”) revenue to $1,540,000 from $301,000 in […]

Sigyn Therapeutics (OTCQB: SIGY, SIGYD), a development-stage medical technology company, has released its year-end 2023 financials and additionally disclosed the completion of a 1-for-40 reverse split of its common stock was implemented on January 31, 2024. As a result of this split, Sigyn’s common stock will trade under the ticker symbol “SIGYD” for 20 business […]

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the registered direct offering for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 – at the market under Nasdaq rules – per share yielded approximately $3.6 million in gross proceeds. This was offered […]

Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation, just announced its strategic partnership with Carbonsight (by Autocase). This move brings together Carbonsight’s cutting-edge decarbonization planning software and Correlate’s expertise in developing and financing renewable and clean energy projects, together helping businesses transition to […]

Activist investors remain a force to be reckoned with. They target companies perceived to be underperforming or inefficient and implement strategies to maximize shareholder value. That’s why they’re also called value investors. Indicators of underperformance that grab their attention include stagnant stock prices, low profitability, inefficient resource utilization, governance deficiencies, regulatory scrutiny, and operation in […]

Quant Strats invites thought leaders, c-suite representatives, and executives from all over the globe, for a flourishing debate and discussion on the key trends and changes in the industry, with a specific focus on real-life applications. The Quant Strats Conference, taking place March 12th, 2024, is the leading event for quantitative thought leaders, where you […]

In San Francisco, the epicenter of last year’s nationwide downturn in the commercial real estate market with a similar slump in housing, real estate agents are seeing signs of new life as open houses draw surging numbers of visitors and stronger YOY sales. “Open house visitor numbers have surged, new listings coming on market have […]

North American mining and jewelry-making company GEMXX (OTC: GEMZ) is reporting the latest evidence that last year’s gamble on the gold market has paid off, bringing the mine-to-market enterprise a remarkable 600 percent YOY increase in the value of its product deliveries. Approaching the end of February, gold prices continued to hold steady above the […]

James A. Joyce, the Chairman and CEO of development-stage medical technology company Sigyn Therapeutics (OTCQB: SIGYD, SIGY), recently discussed the company’s opportunities, challenges, and decision-making processes in a letter to shareholders (https://ibn.fm/wGTqS). The company is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health: Sigyn Therapeutics designed […]